These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 30969503)

  • 1. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.
    Rauer S; Marks R; Urbach H; Warnatz K; Nath A; Holland S; Weiller C; Grimbacher B
    N Engl J Med; 2019 Apr; 380(17):1676-1677. PubMed ID: 30969507
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.
    Walter O; Treiner E; Bonneville F; Mengelle C; Vergez F; Lerebours F; Delobel P; Liblau R; Martin-Blondel G;
    N Engl J Med; 2019 Apr; 380(17):1674-1676. PubMed ID: 30969500
    [No Abstract]   [Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
    Holmes A; Wellings T; Walsh O; Rowlings P
    J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
    Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
    Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
    Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
    J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV.
    Pinnetti C; Cimini E; Vergori A; Mazzotta V; Grassi G; Mondi A; Forbici F; Amendola A; Grisetti S; Baldini F; Candela C; Casetti R; Campioni P; Capobianchi MR; Agrati C; Antinori A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy treated with nivolumab.
    Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
    J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control.
    Schwab N; Ulzheimer JC; Fox RJ; Schneider-Hohendorf T; Kieseier BC; Monoranu CM; Staugaitis SM; Welch W; Jilek S; Du Pasquier RA; Brück W; Toyka KV; Ransohoff RM; Wiendl H
    Neurology; 2012 Feb; 78(7):458-67; discussion 465. PubMed ID: 22302546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
    Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
    JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.
    Sanjo N; Nose Y; Shishido-Hara Y; Mizutani S; Sekijima Y; Aizawa H; Tanizawa T; Yokota T
    J Neurol; 2019 Feb; 266(2):369-377. PubMed ID: 30511098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
    Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
    Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.
    Tan CS; Bord E; Broge TA; Glotzbecker B; Mills H; Gheuens S; Rosenblatt J; Avigan D; Koralnik IJ
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):244-8. PubMed ID: 22549384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
    Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
    Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
    BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
    Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
    Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.
    Van Loy T; Thys K; Ryschkewitsch C; Lagatie O; Monaco MC; Major EO; Tritsmans L; Stuyver LJ
    J Virol; 2015 Jan; 89(2):1340-7. PubMed ID: 25392214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
    Beck ES; Cortese I
    Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
    Muftuoglu M; Olson A; Marin D; Ahmed S; Mulanovich V; Tummala S; Chi TL; Ferrajoli A; Kaur I; Li L; Champlin R; Shpall EJ; Rezvani K
    N Engl J Med; 2018 Oct; 379(15):1443-1451. PubMed ID: 30304652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.